Oncol Lett 14: [Related article:] 2864–2868, 2017; DOI:
10.3892/ol.2017.6527
Following the publication of this paper, it was drawn
to the Editor's attention by a concerned reader that, regarding the
immunohistochemical data shown in Fig. 6, the TrkA and p75NTR
panels appeared to show an overlap, albeit the images were
stretched differently. Furthermore, in the “Patients with ovarian
cancer” column, the NGF and p75NTR panels also appeared to show an
overlap, again with a different stretching factor. Finally, the
distribution and coloring of these samples appeared to be very
different comparing between the two columns, as if different
stainings may have been applied: The reader considered that the
left column may have shown H&E staining experiments, whereas
the right column panels appeared to have been stained with an
antibody.
Upon performing an independent analysis of the data
in this paper in the Editorial Office, it came to light that
certain of the data in Fig. 6 were strikingly similar to data that
had already been submitted for publication in an article written by
different authors at different research institutes, also to the
journal Oncology Letters.
Owing to the fact that the contentious data in the
above article had already been submitted for publication prior to
its submission to Oncology Letters, the Editor has decided
that this paper should be retracted from the Journal. The authors
were asked for an explanation to account for these concerns, but
the Editorial Office did not receive a reply. The Editor apologizes
to the readership for any inconvenience caused.
